Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun 28:8:F1000 Faculty Rev-980.
doi: 10.12688/f1000research.16182.1. eCollection 2019.

What's new in HIV dermatology?

Affiliations
Review

What's new in HIV dermatology?

Sarah J Coates et al. F1000Res. .

Abstract

HIV has long been associated with a number of inflammatory, infectious, and neoplastic skin conditions. In the era of anti-retroviral therapy, we have discovered even more about the relationship between skin disease and chronic immunosuppression. In particular, clinicians still face the propensity of persons living with HIV to develop difficult-to-control viral infections, chronic skin inflammation, and pruritus and-particularly as patients age-various types of skin cancers. Here, we summarize recent updates in the field of HIV dermatology and make recommendations to providers caring for these patients.

Keywords: HIV; Kaposi sarcoma; Merkel cell carcinoma; atopic dermatitis; dermatology; herpes simplex virus; human papilloma virus; nonmelanoma skin cancer; prurigo nodularis; pruritus; psoriasis; syphilis; varicella zoster virus.

PubMed Disclaimer

Conflict of interest statement

No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.

Similar articles

Cited by

References

    1. UNAIDS: Miles to go—closing gaps, breaking barriers, righting injustices. UNAIDS.2018. Reference Source
    1. Siegenbeek van Heukelom ML, Marra E, de Vries HJC, et al. : Risk factors for anal high-grade squamous intraepithelial lesions in HIV-positive MSM: is targeted screening possible? AIDS. 2017;31(16):2295–301. 10.1097/QAD.0000000000001639 - DOI - PMC - PubMed
    2. F1000 Recommendation

    1. Bacik LC, Chung C: Human papillomavirus-associated cutaneous disease burden in human immunodeficiency virus (HIV)-positive patients: the role of human papillomavirus vaccination and a review of the literature. Int J Dermatol. 2018;57(6):627–34. 10.1111/ijd.13819 - DOI - PubMed
    2. F1000 Recommendation

    1. CDC: Human Papillomavirus. Natl. Cent. Immun. Respir. Dis. 2018; [cited 2018 Aug 18]. Reference Source
    1. Kahn JA, Xu J, Kapogiannis BG, et al. : Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women. Clin Infect Dis. 2013;57(5):735–44. 10.1093/cid/cit319 - DOI - PMC - PubMed